ReNeuron Group (RENE)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 42.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 148.50
  • 52 Week Low: 39.50
  • Currency: UK Pounds
  • Shares Issued: 57.06m
  • Volume: 0
  • Market Cap: £23.97m
  • RiskGrade: 394
  • Beta: 0.08

ReNeuron Group Overview

ReNeuron Group is in the pharma and biotech sector and is currently trading at 42.00p per share. In the last year ReNeuron Group's share price has ranged from 39.50p to 148.50p and brokers are currently rating this stock as 'strong buy'.

1 Day Chart (20-01-2022)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -4965.4% -5251.7%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 92.2 95.9
Pr/Book 1.3  
Latest F'cast
Revenue -95.7% -3.8%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

ReNeuron Group Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-17 0.05 (18.16) (4,790.53)p n/a n/a n/a n/a 0.0%
31-Mar-18 0.04 (20.97) (54.23)p n/a n/a n/a n/a 0.0%
31-Mar-19 0.05 (17.23) (44.11)p n/a n/a n/a n/a 0.0%
31-Mar-20 6.07 (13.86) (34.96)p n/a n/a n/a n/a 0.0%
31-Mar-21 0.26 (13.41) (29.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

ReNeuron Group Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-22 0.25 (13.13) (20.94)p n/a n/a n/a n/a 0.0%
31-Mar-23 0.53 (14.49) (22.84)p n/a n/a n/a n/a 0.0%
31-Mar-24 n/a (20.90) (32.30)p n/a n/a n/a n/a 0.0%

Copyright © 2022 FactSet Research Systems Inc. All rights reserved.

ReNeuron Group Company Announcements

Price Monitoring Extension 18-Jan-2022 16:35 RNS
Second Price Monitoring Extn 18-Jan-2022 14:06 RNS
Price Monitoring Extension 18-Jan-2022 14:00 RNS

Latest ReNeuron Group Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

ReNeuron Group Market Data

Currency UK Pounds
Share Price 42.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 148.50
52 Week Low 39.50
Volume 0
Shares Issued 57.06m
Market Cap £23.97m
Beta 0.08
RiskGrade 394

ReNeuron Group Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
23.94% above the market average23.94% above the market average23.94% above the market average23.94% above the market average23.94% above the market average
22.45% above the sector average22.45% above the sector average22.45% above the sector average22.45% above the sector average22.45% above the sector average
Price Trend
97.39% below the market average97.39% below the market average97.39% below the market average97.39% below the market average97.39% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Income Not Available
Growth
26.94% above the market average26.94% above the market average26.94% above the market average26.94% above the market average26.94% above the market average
25.71% above the sector average25.71% above the sector average25.71% above the sector average25.71% above the sector average25.71% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

ReNeuron Group Dividends

No dividends found

Trades for --2022

Time Volume / Share Price
0 @ 0.000p

ReNeuron Group Key Personnel

CEO Olav Hellebø
CFO Catherine Isted

Top of Page